Insights into the success and failure of systemic therapy for hepatocellular carcinoma

Nature Reviews. Gastroenterology & Hepatology
Jordi BruixMaría Reig

Abstract

Systemic treatment for hepatocellular carcinoma (HCC) has been boosted by the incorporation of new agents after many negative phase III trials in the decade since the approval of sorafenib. Sorafenib introduced the concept that targeting specific hallmarks of hepatocarcinogenesis could modify the dismal prognosis of this disease, with the drug remaining a cornerstone in the upfront therapy for advanced HCC. The design of clinical trials in this malignancy is complicated by important obstacles related to patient selection, prognostic assessment and the need for endpoints that correlate with improvement in survival outcomes. In addition, the currently used criteria to determine treatment response or progression might prevent physicians from making appropriate clinical judgements and interpreting evidence arising from trials. In this Review, we discuss the advances in systemic therapy for HCC and critically review trial designs in HCC. Although novel therapies, such as new targeted agents and immunotherapies, are being rapidly incorporated, it is paramount to design future clinical trials based on the lessons learned from past failures and successes.

References

May 13, 1978·Lancet·P J JohnsonI M Murray-Lyon
Jan 1, 1981·Cancer·A B MillerA Winkler
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Jul 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Maindrault-GoebelA de Gramont
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Jun 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabiola DelcòStephan Krähenbühl
Apr 22, 2006·Nature Reviews. Drug Discovery
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G GishGerard T Kennealey
Jul 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mercedes FernandezJaime Bosch
Oct 16, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sònia TuguesManuel Morales-Ruiz
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jan 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc MejiasMercedes Fernandez
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Jun 22, 2010·Journal of Hepatology·Jaume BoschJuan Carlos García-Pagán
Dec 31, 2010·Clinical Pharmacology and Therapeutics·K I Kaitin, J A DiMasi
Mar 25, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O AmitH U Burger
Jun 17, 2011·The New England Journal of Medicine·Syed W YusufJean-Bernard Durand
Mar 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Jun 22, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria ReigJordi Bruix
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J JohnsonAnn-Lii Cheng
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep M LlovetJoong-Won Park
Oct 2, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann-Lii ChengEric Raymond

❮ Previous
Next ❯

Citations

Jul 3, 2020·PloS One·Christine KochMartin-Walter Welker
May 12, 2020·World Journal of Gastroenterology : WJG·Federico PiñeroMassimo Iavarone
Apr 8, 2020·Journal of Hepatocellular Carcinoma·Dana A Dominguez, Xin Wei Wang
Sep 11, 2020·BioMed Research International·Yipeng ZhangChangchun Zeng
Feb 18, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alessandro VitaleUmberto Cillo
Jun 20, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Roman KloecknerJordi Bruix
Nov 15, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Maria ReigAndrew X Zhu
Dec 11, 2020·Journal of Cellular and Molecular Medicine·Junyu HuoYunjin Zang
Feb 9, 2021·Frontiers in Cellular and Infection Microbiology·Md Arifur RahmanTomoyuki Honda
Feb 12, 2021·Science Translational Medicine·Hassan AlbadawiRahmi Oklu
Nov 3, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Leonardo G Da Fonseca, Alejandro Forner
Jan 29, 2021·Liver International : Official Journal of the International Association for the Study of the Liver·Yong YiShuang-Jian Qiu
May 11, 2021·AMB Express·Haobin ZhaoJunling Shi
Jun 3, 2021·International Journal of Molecular Sciences·Jitka SoukupovaIsabel Fabregat
May 20, 2021·Journal of Clinical and Translational Hepatology·Junyu HuoYunjin Zang
Jun 30, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shukui QinFeng Chen
Jul 3, 2021·Cancers·Ester Gonzalez-SanchezIsabel Fabregat
Jul 10, 2021·World Journal of Gastroenterology : WJG·Federico Piñero, Leonardo Gomes da Fonseca
Jul 3, 2021·Current Oncology·Ritu ShresthaAparna Jayachandran
Jul 19, 2021·Clinical and Experimental Medicine·Yue LiXiming Xu
Jul 23, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robin Kate KelleyGhassan K Abou-Alfa
Jul 14, 2021·Journal of Hepatology·Jordi BruixBruno Sangro

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
biopsy

Clinical Trials Mentioned

NCT02702401
NCT03033446
NCT03099564

Software Mentioned

mRECIST

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Expert Review of Anticancer Therapy
Matthew D Galsky, Nicholas J Vogelzang
Journal of Gastroenterology and Hepatology
Stephen L Chan, Winnie Yeo
© 2021 Meta ULC. All rights reserved